AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2005
Jul 29, 2005
34152_dirs_2005-07-29_2453f3d8-d19f-429e-af23-91c566d6275f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-07-27
Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-07-27 | Common Stock, par value $0.01 per share | S | 14800 | $0.81 | Disposed | 11887148 | Indirect |
| 2005-07-27 | Common Stock, par value $0.01 per share | S | 100 | $0.81 | Disposed | 11887048 | Indirect |
| 2005-07-27 | Common Stock, par value $0.01 per share | S | 6600 | $0.82 | Disposed | 11880448 | Indirect |
| 2005-07-28 | Common Stock, par value $0.01 per share | S | 15000 | $0.80 | Disposed | 11865448 | Indirect |
Footnotes
F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA, Inc., fka Biogen, Inc.
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23